Teva Pharmaceuticals Industries Ltd. has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023. Current CEO, Kåre Schultz, will retire effective December 31, 2022.   Richard Francis, President and CEO Mr. Francis is a seasoned pharmaceutical executive with more than two and a half decades of experience, including five years as Chief Executive Officer of Sandoz and a member of the Novartis Executive Team. Prior to his role at Sandoz, Mr. Francis wa...